Ho Beng-Choon, Barry Amy B, Koeppel Julie A, Macleod John, Boyd Andy, David Anthony, O'Leary Daniel S
Department of Psychiatry, University of Iowa Carver College of Medicine, Iowa City, Iowa.
Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom.
Biol Psychiatry Glob Open Sci. 2022 Feb 8;3(2):222-232. doi: 10.1016/j.bpsgos.2022.01.008. eCollection 2023 Apr.
We investigated how low marijuana (MJ) use levels, the typical use pattern in most adolescent users, affect cognitive maturation and schizophrenia risk.
In two complementary adolescent samples where the majority reported minimal MJ use, we compared cognitive performances before and after MJ use initiation. The Iowa sample (40 first-degree relatives and 54 second-degree relatives of patients with schizophrenia and 117 control subjects with no schizophrenia family history) underwent a battery of standardized neuropsychological tests at 0, 18, and 36 months. Based on self-administered Timeline Followback interviews, 26.5% of adolescents had emergent MJ use (eMJ) during follow-up. The second sample ( = 3463), derived from a birth cohort, received substance use and sustained attention assessments between ages 10 and 15 years. Mixed linear models and regression analyses tested the effects of eMJ on longitudinal changes in cognitive performance.
In the Iowa sample, longitudinal changes in 5 of 8 cognitive domains were significantly associated with eMJ. On sustained attention, visuospatial working memory, and executive sequencing, adolescents with eMJ showed less age-expected improved performance. In addition, first-degree relatives with eMJ were less improved on processing speed and executive reasoning than first-degree relatives without eMJ. In the birth cohort, greater intraindividual variability in reaction times (indicative of poorer sustained attention) was significantly associated with more frequent MJ use and with recreational use levels.
Nonheavy MJ use disrupts normal adolescent maturation and compounds aberrant adolescent maturation associated with familial schizophrenia risk. These findings underscore the importance of reducing adolescent MJ access in the context of increased availability to high-potency MJ.
我们研究了低水平大麻(MJ)使用情况(这是大多数青少年使用者的典型使用模式)如何影响认知成熟和精神分裂症风险。
在两个互补的青少年样本中,大多数人报告使用大麻的量极少,我们比较了开始使用大麻前后的认知表现。爱荷华样本(40名精神分裂症患者的一级亲属和54名二级亲属以及117名无精神分裂症家族史的对照受试者)在0、18和36个月时接受了一系列标准化神经心理学测试。根据自我管理的时间线回溯访谈,26.5%的青少年在随访期间开始使用大麻(eMJ)。第二个样本(n = 3463)来自一个出生队列,在10至15岁之间接受了物质使用和持续注意力评估。混合线性模型和回归分析测试了eMJ对认知表现纵向变化的影响。
在爱荷华样本中,8个认知领域中的5个领域的纵向变化与eMJ显著相关。在持续注意力、视觉空间工作记忆和执行序列方面,使用eMJ的青少年表现出的年龄预期改善较少。此外,使用eMJ的一级亲属在处理速度和执行推理方面的改善不如未使用eMJ的一级亲属。在出生队列中,反应时间的个体内变异性更大(表明持续注意力较差)与更频繁的大麻使用和娱乐性使用水平显著相关。
非大量使用大麻会扰乱青少年的正常成熟,并加剧与家族性精神分裂症风险相关的异常青少年成熟。这些发现强调了在高效能大麻可得性增加的背景下减少青少年获取大麻的重要性。